|
|
|
U.S. court rules against Bayer's Yasmin patent
Headline Legal News |
2008/03/03 19:20
|
| A U.S. district court ruled against the validity of Bayer Schering Pharma's patent for its contraceptive drug Yasmin, the German drug company said late on Monday. This was the result of a patent challenge by generic manufacturer Barr Laboratories, Bayer said in a statement. "Bayer disagrees with the court's decision and will consider its legal options in this regard," the company added. Bayer Schering's contraceptive drug Yasmin has annual sales of more than one billion euros. Sales of Yasmin in the United States came in at 321 million euros ($486.9 million) last year, it said. |
|
|
|
|
|
|
 |
Investment Fraud Litigation |
|
|
|
|
Securities fraud, also known as stock fraud and investment fraud, is a practice that induces investors to make purchase or sale decisions on the basis of false information, frequently resulting in losses, in violation of the securities laws. Securities Arbitration. Generally speaking, securities fraud consists of deceptive practices in the stock and commodity markets, and occurs when investors are enticed to part with their money based on untrue statements.
|
|
|
| |
| |
| |
|
The content contained on the web site has been prepared by Securities Law News as a service to the internet community and is not intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case. | Affordable Law Firm Website Design by Law Promo |
|
Legal News RSS Feed
